Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

New hires at bluebird bio, BioNTech and Provention Bio

New hires at bluebird bio, BioNTech and Provention Bio

Prior to Celgene, she served in a number of roles at Shire, including as group vice president, investor relations.

Takeda’s subcutaneous Entyvio formulation faces FDA rejection

Takeda’s subcutaneous Entyvio formulation faces FDA rejection Takeda is also betting on pipeline products from its £46bn takeover of Irish biotech Shire to offset loss from patent challenges, although home-grown products like Entyvio are important too as

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day

Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day Just under a year after closing its $62bn acquisition of Shire, Takeda has laid out the highlights of its new pipeline, pointing to 12 new drugs with the potential to launch

Takeda divests over-the-counter and prescription drugs to Stada for $660m

Takeda divests over-the-counter and prescription drugs to Stada for $660m focus on its five key business areas and takeover of Irish biotech Shire. ... In addition to focusing on its key growth areas, Takeda is completing the divestments to accelerate its acquisition of Shire, which it announced in  2018.

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover According to a statement from Takeda, it will use the cash from the deal to reduce its debts, following its takeover of Shire. ... However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

The balancing act that’s keeping pharma and biotech market access on its toes
Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...
Pills
Tackling antimicrobial resistance on multiple fronts
An urgent change of direction is needed in how we respond to AMR...
Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...

Infographics